Prevention of depression through nutritional strategies in high-risk persons: rationale and design of the MooDFOOD prevention trial.Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National StudyPrevention of suicidal behavior.The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany.Time perception at different EEG-vigilance levelsIn-vivo analysis of the human planum temporale (PT): does the definition of PT borders influence the results with regard to cerebral asymmetry and correlation with handedness?Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.Optimizing suicide prevention programs and their implementation in Europe (OSPI Europe): an evidence-based multi-level approach."Onset of Depression Inventory"--comparison between the data of depressed patients and their relatives.Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?Suicide prevention strategies: a systematic review.Internet-Delivered Disease Management for Recurrent Depression: A Multicenter Randomized Controlled Trial.Avoiding the ballistocardiogram (BCG) artifact of EEG data acquired simultaneously with fMRI by pulse-triggered presentation of stimuli.ICA-based muscle artefact correction of EEG data: what is muscle and what is brain? Comment on McMenamin et al.Genetic association of objective sleep phenotypes with a functional polymorphism in the neuropeptide S receptor gene.Drug suicide: a sex-equal cause of death in 16 European countries.Who receives depression-specific treatment? A secondary data-based analysis of outpatient care received by over 780,000 statutory health-insured individuals diagnosed with depression.Depression in the workplace: a systematic review of evidence-based prevention strategies.Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression.Structural studies of the hypothalamus and its nuclei in mood disorders.The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: a genetic association study.Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease.Suicide prevention strategies revisited: 10-year systematic review.Developing social capital in implementing a complex intervention: a process evaluation of the early implementation of a suicide prevention intervention in four European countries.Preference of lethal methods is not the only cause for higher suicide rates in males.What Are Reasons for the Large Gender Differences in the Lethality of Suicidal Acts? An Epidemiological Analysis in Four European Countries.The serotonin syndrome scale: first results on validity.Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-Tesla magnetic resonance imagesWhy has the continuous decline in German suicide rates stopped in 2007?Insufficient depression treatment in outpatient settings.Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression?Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials.Prestimulus vigilance predicts response speed in an easy visual discrimination task.Inflammatory cytokines in general and central obesity and modulating effects of physical activity.Johann Christian August Heinroth on sleep deprivation as a therapeutic option for depressive disorders.The evaluation of suicide prevention activities: state of the art.Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s.Best practice elements of multilevel suicide prevention strategies: a review of systematic reviews.
P50
Q27310971-5DCD714A-565C-4D03-B902-DE3A7BF466E0Q28681287-AB65D6F7-DE58-4E22-AFF9-A3897C92C690Q30377357-9EE5473D-9B2C-4D9B-8B63-89974763DDC8Q30406451-147B336E-F5D6-4207-BEDE-139838758AD7Q30460424-0C8612F1-DF14-4D9D-A3C4-006208893D76Q30659521-E870EFA1-8044-45E0-8425-11043AA0628DQ30870493-35F3C387-BCA8-4868-9A71-381682ABAB59Q30907937-D181CFC1-3000-42C4-8637-D5EBCA47447CQ30908612-FBF6DEE7-5799-4516-9E5A-A2478BF6936BQ30996080-626AE9B8-0A15-4EA9-A8C7-E97780664251Q31925071-DEDA8DF3-CB2D-45CF-B35A-2EBEA86F29A9Q33225970-82F528AB-918E-4B09-9B6D-AD9B9478A702Q33446928-0D983AD5-C42D-4DD8-95B6-8D643C12B813Q33516420-449FEDFB-5B26-40F2-96CC-B4A3FC507E90Q33571484-E29E5AD8-9A1A-4C0D-B331-5ACFEFBEB975Q33712096-B7B8DC57-DC33-4F8B-828F-AB62DA707608Q33806440-CC744176-2DAA-4607-8A0D-686DDDDE565AQ33829690-91F072F4-AF58-4FD3-8332-85F09773B806Q33861671-C80A5113-3BF8-44C0-9CC7-FF7A8EAB3ABCQ34024650-CE785968-7D09-4FD9-842D-D28DC9CE025EQ34121502-715F617A-AB67-44BA-8EE3-3AE62692A0C8Q34143738-2E1AE971-334F-4E3F-874F-6AFF57AF470BQ34309220-06F5019A-B63C-435A-9DE0-81248166C8B1Q34344331-4F2CC9E7-6AD9-4C7F-AC58-884EBFEDF63EQ34530580-9AE2CBCE-7B79-4071-A6CF-9F05EBF36D46Q34593029-B8D501FD-9A0D-467E-83B3-61B9BFF139B2Q34632499-537F055A-BC38-4FB5-A58F-FBE1C49DC066Q34671268-36ADBEEB-A97E-4FF1-9877-51406ACBE17BQ34749913-BB97D394-28C9-4BF6-B044-7A920E17B57BQ34917581-6AFE0610-AD4D-42E1-9CC7-472B0C1D3E48Q34964191-5A018ED6-A15A-475B-9222-441476FE8FBAQ34997104-002C5882-F30D-458D-8011-1C6F21466B59Q35009098-A4321436-9851-4D77-9751-0D36795430ADQ35073817-54785FFC-CA93-400D-94FD-990E40E6E024Q35184960-CC522FBD-5191-4655-9101-99B09A754528Q35187378-F7077A75-A30D-435C-AAD7-05DBD374B0B7Q35201197-DAC39DEB-566C-43A4-BF41-9E64EFC0D0E7Q35580184-108CA71C-E05B-45C7-A990-9EF85CA78AF8Q35775031-82DB13BA-ED20-49F4-99BB-17CCB9F7EADCQ35835977-89B17375-1DA4-465C-93FF-0132C8CECC08
P50
description
deutscher Psychiater und Vorsitzender der Stiftung Deutsche Depressionshilfe
@de
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ulrich Hegerl
@ast
Ulrich Hegerl
@de
Ulrich Hegerl
@en
Ulrich Hegerl
@eo
Ulrich Hegerl
@es
Ulrich Hegerl
@nl
Ulrich Hegerl
@ro
Ulrich Hegerl
@sl
type
label
Ulrich Hegerl
@ast
Ulrich Hegerl
@de
Ulrich Hegerl
@en
Ulrich Hegerl
@eo
Ulrich Hegerl
@es
Ulrich Hegerl
@nl
Ulrich Hegerl
@ro
Ulrich Hegerl
@sl
prefLabel
Ulrich Hegerl
@ast
Ulrich Hegerl
@de
Ulrich Hegerl
@en
Ulrich Hegerl
@eo
Ulrich Hegerl
@es
Ulrich Hegerl
@nl
Ulrich Hegerl
@ro
Ulrich Hegerl
@sl
P214
P227
P106
P19
P21
P214
P227
P2798
P31
P496
0000-0002-3039-7470
P569
1953-06-05T00:00:00Z
P735
P7859
viaf-209294934